dc.contributor.author | Hiraga, Shin-ichiro | |
dc.contributor.author | Ly, Tony | |
dc.contributor.author | Garzon, Javier | |
dc.contributor.author | Hořejší, Zuzana | |
dc.contributor.author | Ohkubo, Yoshi-nobu | |
dc.contributor.author | Endo, Akinori | |
dc.contributor.author | Obuse, Chikashi | |
dc.contributor.author | Boulton, Simon J. | |
dc.contributor.author | Lamond, Angus I. | |
dc.contributor.author | Donaldson, Anne D. | |
dc.date.accessioned | 2017-03-02T14:28:18Z | |
dc.date.available | 2017-03-02T14:28:18Z | |
dc.date.issued | 2017-03-01 | |
dc.identifier.citation | Hiraga , S , Ly , T , Garzon , J , Hořejší , Z , Ohkubo , Y , Endo , A , Obuse , C , Boulton , S J , Lamond , A I & Donaldson , A D 2017 , ' Human RIF1 and protein phosphatase 1 stimulate DNA replication origin licensing but suppress origin activation ' , EMBO reports , vol. 18 , no. 3 , pp. 403-419 . https://doi.org/10.15252/embr.201641983 | en |
dc.identifier.issn | 1469-221X | |
dc.identifier.other | PURE: 68244695 | |
dc.identifier.other | PURE UUID: ff68c143-51fc-43eb-a870-cd1bad4e8a59 | |
dc.identifier.other | Scopus: 85010540265 | |
dc.identifier.other | ORCID: /0000-0002-8722-3869/work/29423912 | |
dc.identifier.other | ORCID: /0000-0002-5093-8385/work/46964299 | |
dc.identifier.uri | http://hdl.handle.net/2164/8280 | |
dc.description | We thank David Stead at the Aberdeen Proteomics Service for help in mass spectrometry interpretation, and Raif Yücel and his team at the University of Aberdeen Iain Fraser Cytometry Centre for assistance with flow cytometry. We thank Robert Alver and Julian Blow at University of Dundee for advice on the use of tautomycetin. Peter Cherepanov of the Francis Crick Institute gifted XL413. Daniel Durocher of Lunenfeld-Tanenbaum Research Institute gifted DNA constructs. Work by ADD and SH was supported by Cancer Research UK Grant A13356, Cancer Research UK Programme Award A19059, and BBSRC grant (BB/K006304/1). AIL was supported by Wellcome Trust Awards (108058/Z/15/Z & 105024/Z/14/Z). This work was also supported by JSPS KAKENHI Grant # 16H04739, 25116004 to CO and 16J04327 to YO. | en |
dc.format.extent | 17 | |
dc.language.iso | eng | |
dc.relation.ispartof | EMBO reports | en |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | RIF1 | en |
dc.subject | PP1 | en |
dc.subject | origin licensing | en |
dc.subject | ORC1 | en |
dc.subject | MCM | en |
dc.subject | QH301 Biology | en |
dc.subject | Cancer Research UK | en |
dc.subject | A13356 | en |
dc.subject | A19059 | en |
dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
dc.subject | BB/K006304/1 | en |
dc.subject | Wellcome Trust | en |
dc.subject | 108058/Z/15/Z | en |
dc.subject | 105024/Z/14/Z | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | QH301 | en |
dc.title | Human RIF1 and protein phosphatase 1 stimulate DNA replication origin licensing but suppress origin activation | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Clinical Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.15252/embr.201641983 | |